Biotechnology Eye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drug – Regeneron Pharmaceuticals (NASDAQ:REGN) Read more
Cannabis Flora Growth’s Stock Trading Higher On Pricing $3.2M Public Offering Of Common Shares – Flora Growth (NASDAQ:FLGC) Read more
Stockmarkets MP Materials stock target cut to $22 on revised NdPr pricing By biedexmarkets.com Read more
Biotechnology Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering – Clearside Biomedical (NASDAQ:CLSD) Read more